Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca LP v. Mylan Inc. (N.D.W. Va. 2015)

See Plans and Pricing

« Back to Dashboard

AstraZeneca LP v. Mylan Inc. (N.D.W. Va. 2015)

Docket   Start Trial Date Filed 2015-11-02
Court District Court, N.D. West Virginia Date Terminated 2017-07-19
Cause 35:145 Patent Infringement Assigned To Irene Patricia Murphy Keeley
Jury Demand None Referred To
Patents 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934
Attorneys Charles E. Lipsey; Gordon H. Copland; James F. Companion; James H. Wallace , Jr.; Jill K. MacAlpine; Mark A. Pacella; Mark J Feldstein; Ryan P. O'Quinn; William J O'Brien; Yolonda G. Lambert
Firms Finnegan Henderson Farabow Garrett and Dunner; Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Steptoe & Johnson PLLC - Bridgeport; Wiley Rein LLP
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca LP v. Mylan Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for AstraZeneca LP v. Mylan Inc. (N.D.W. Va. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-02 1 prior to expiration of AstraZeneca’s U.S. Patent Nos. 6,251,910 (“the ’910 T.. NOV -2 2015 WVN D Case…Exhibit A - US Patent Information, # 2 Exhibit B - US Patent Information, # 3 Exhibit C - US Patent Information… 14 Page|D #: 2 patent”), 6,525,060 (“the ’060 patent”), 7,250,419 (“the ’419 patent”), 7,265,124 (“the…Information, # 4 Exhibit D - US Patent Information, # 5 Exhibit E - US Patent Information, # 6 Civil Cover Sheet…ACTION l. This is an action for patent infringement arising under the patent laws of the United States, Title External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.